百奥泰生物制药股份有限公司关于参加广东辖区2025年投资者网上集体接待日活动的公告

Group 1 - The company will participate in the "2025 Guangdong Investor Collective Reception Day" to enhance interaction with investors [1] - The event will be held online on September 19, 2025, from 15:30 to 17:00 [1] - Company executives will discuss the 2025 semi-annual performance, corporate governance, development strategy, operational status, and sustainable development [1] Group 2 - The second extraordinary general meeting of shareholders was held on September 15, 2025 [3] - All 9 current directors attended the meeting, along with the company secretary and senior management [5] - Three resolutions were passed, including changes to the registered address and the signing of a licensing and commercialization agreement for BAT1806 [6][6]